You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Tildrakizumab for treating moderate to severe plaque psoriasis

  • Technology appraisal guidance
  • Reference number: TA575
  • Published:  17 April 2019
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendations coming out of this guidance

  • What are the costs associated with best supportive care? 

Back to top